Clinical trials offer healthy potential for Scotland
As participation in clinical research falls, Alison Culpan Director of the ABPI in Scotland looks at why Scotland should be investing in this multi-million pound activity. Phase 3 clinical trials,…
‘Our role is to get the ideas out of the university’
Collaboration between academia, government and the NHS is crucial in the life sciences sector – and that’s where Edinburgh Innovations comes in We have come a long way from the…
CPI joins Sustainable Medicines Partnership
CPI, a leading independent technology innovation centre and a founding member of the UK Government’s High Value Manufacturing Catapult, has joined the YewMaker-led Sustainable Medicines Partnership (SMP) to improve the…
Why companies need to act now on international data transfers
With the multiple impacts of Brexit, Covid-19 and the cost of living crisis, life sciences businesses may not have data protection at the forefront of their minds. However, privacy laws…
Mission possible
The vision for Scotland’s life sciences sector was for it to be worth £8 billion by 2025. That was before Covid and Brexit. How is it faring? Few of us…
